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KLAUS VON OLSHAUSEN, MD, CARL J. SCHUSTER, MD, HANS-JORGEN RUPPRECHT, MD,
CLAUS STEUERNAGEL, CAND MED, JORGEN MEYER, MD
Mainz , West Germany
In 162 patients with acute transmural myocardial in-
farction, combined intravenous and intracoronary
thrombolytic therapy with streptokinase was initiated.
In vessels that remained occluded, mechanical recanal-
ization was performed with a 3F recanalization catheter
(group I, n = 79) or a 4F Griintzig balloon catheter
(group II, n = 83). After reperfusion, intracoronary
streptokinase was administered superselectively. After
termination of streptokinase infusion, angioplasty was
performed only in patients in group II. There was no
difference between the groups in relation to sex, age,
infarct location, creatine kinase levels and time between
onset of symptoms and start of treatment. Initial coro-
nary angiography showed an open vessel in 27 (34%) of
79 patients in group I and 21 (25%) of 83 patients in
group II. The final reperfusion rate was 90% (71 of 79)
in group I and 86% (71 of 83) in group II. Angioplasty
was attempted iri 69 of the 71 patients in group II with
a success rate of 65% and an occlusion rate of 3%.
During the hospital stay, reocclusion occurred in 14
Rapid restoration of coronary blood flow seems to be the
aim of therapy in acute myocardial infarction. Intravenous
(1-6) and intracoronary application of streptokinase (7-12)
and urokinase (13,14) can restore coronary blood flow by
thrombolysis. Acylated streptokinase-plasminogen complex
(BRL 26921) (15) and tissue plasminogen activators (16,17)
also can be used. A combination of intracoronary and in-
travenous routes of administration seems to be effective in
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(20%) of 71 patients in group I. After thrombolytic ther-
apy, coronary luminal narrowing in group I was 75 ±
17% in patients without and 87 ± 6% in patients with
reocclusion (p < 0.05). In group II, reocclusion was
found in 10 (14%) of 71 patients. After angioplasty, the
degree of coronary stenosis in group II was reduced from
82 ± 12 to 51 ± 30% (p < 0.001). Reocclusion was
found in 3 (7%) of the 45 patients with successful an-
gioplasty and in 7 (32%) of the 22 patients with unsuc-
cessful angioplasty (p < 0.01). Improvement in regional
left ventricular function was observed only in patients
from group II with anterior myocardial infarction.
In conclusion, by combined medical and mechanical
recanalization, the rate of coronary reperfusion can be
increased and infarct time shortened, providing the pos-
sibility of full revascularization by angioplasty, with hit-
provement of regional wall motion and reduction of the
rate of reocclusion.
(J Am Coil CardioI1986;8:485-95)
increasing the rate of open vessels at the time of initial
coronary angiography (18,19) . A combination of throm-
bolytic therapy with mechanical recanalization (coronary
angioplasty) was recommended to increase the rate of re-
canalization and reduce reperfusion time (20- 22). Indepen-
dent of the method of reperfusion , high reocclusion rates
are observed, ranging from 13% (9) to 27% (10) depending
on the degree of luminal narrowing of the coronary arteries.
On the basis of these observations we introduced per-
cutaneous transluminal coronary angioplasty after success-
ful thrombolytic therapy (23) to reduce residual coronary
luminal narrowing and thus the risk of reocclusion. In this
prospective randomized study of patients with acute myo-
cardial infarction, we evaluated the effect of thrombolytic
therapy with and without additional coronary angioplasty
on left ventricular function and the rate of reocclusion before
hospital discharge.
0735-1097/86/$3 .50
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Methods
Patients. The study group comprised 162 consecutive
patients who were admitted to the emergency ward of the
Medical Clinic of the University of Mainz within 6 hours
after the onset of symptoms of acute myocardial infarction
and who gave informed consent for the study. Diagnosis
was based on 1) acute chest pain lasting for more than 30
minutes, 2) persistent ST segment elevation of more than
0.3 mV in leads VI to V6 or 0.2 mV in leads I to III, aVL
or aVF. Exclusion criteria were: 1) resuscitation, 2) history
of allergic reaction to streptokinase, 3) previous cerebro-
vascular accident, 4) surgery in the preceding 10 days, 5)
history of acute peptic ulcer, and 6) history of bleeding
problems.
Treatment regimen (Fig. 1) All patients received in-
travenous premedication including 5,000 U heparin, 250
mg prednisolone, 3 mg/h nitroglycerin and 1 g acetylsali-
cylate; 250,000 U streptokinase was infused intravenously
within 20 minutes before cardiac catheterization. Catheter-
ization started with the introduction of a pacing catheter into
the inferior vena cava in anticipation of prophylactic pacing
of the right ventricle in patients with inferior wall myocardial
infarction.
According to the randomization table of Sachs (24), coro-
nary angiography was performed in a random fashion using
a 7F catheter (group I) or a 9F guide catheter (group 11). In
patients with anterior wall myocardial infarction the left
coronary artery was first opacified; also, in those with in-
ferior wall infarction this artery was filmed first because the
infarct-related vessel could not be predicted by means of
the electrocardiogram. After opacification of the occluded
vessel, streptokinase infusion was started immediately with-
out opacification of the contralateral vessel. Coronary an-
giography was followed by injection of a 50,000 U bolus
dose of streptokinase dissolved in saline solution followed
by a continuous regulated infusion of streptokinase in saline
solution at a rate of 4,000 U/min through the coronary
catheter until a total dose of 200,000 U was reached. When
the coronary artery was opened or reperfusion took place
during coronary angiography, the infusion rate was in-
creased to 12,000 U/min. Thus, patients received a total
dose of 500,000 U streptokinase, both intracoronary (250,000
U) and intravenous (250,000 U) (Fig. 1).
During streptolytic therapy, a 3F Gruntzig coronary in-
fusion catheter (recanalization catheter type CI, Schneider
Medintag, Zurich, Switzerland) for group I or a 4F Gruntzig
balloon catheter (Schneider Medintag) for group 11 was pre-
pared (20). As soon as possible the catheter was introduced
into the occluded coronary artery and a flexible guide wire
was advanced through the thrombus for mechanical reca-
nalization and then withdrawn to permit anterograde flow.
Balloon inflation in group 11 was avoided at this time. During
this period, streptokinase administration had to be inter-
rupted for 2 to 4 minutes. Immediately after this procedure
streptokinase was administered superselectively through the
3F or 4F catheter. After administration of the total dose of
streptokinase, coronary angioplasty was attempted in all but
two patients in group II, with successful restoration of coro-
nary blood flow using a 2.0 or 3.7 mm balloon-tipped cath-
eter with steerable wires as well as J and G 20-20 or 20-30
Gruntzig catheters with fixed wires.
After streptolytic therapy, coronary arteriography was
repeated in multiple views and the opposite coronary artery
was visualized. Then biplane left ventricular angiography
was performed using a pigtail catheter with injection of 40
ml of Urografin 70% (Byk Gulden, Konstanz/Germany) at
14 mils. The X-ray equipment was a Siemens biplane Pan-
doros Optimatic Unit (Berlin, Germany) incorporating a
variable mode image intensifier. After completion of the
I.. Emergency Room
~c»u~~ondll
Premedication: 5,000 u heparin
3 mg /h nitroglycerin i.v,
Ig acetylsalicylate acid i.v.
250 mg prednisolone i.v,
Medical Recanalization:
streptokinase 250,000 u/20 min i.v.
II.Cath LabI
c:;roup I
- guiding catheter 7 f
streptokinase 50,000 u bolus
4,000 u/min i.c.
Mechanical Recanalization
- r.canalization-cathete; 3f
- and superseleclive
streptokinase 4,000 u/min occluded vessel
12,000 u/min open vessel
totol dose i.e. 250,000 u
coronary car. unit
\
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- guiding catheter 9f
streptokinase 50,000 u bolus
4,000 u/min i.e,
Mechanical Recanalization
----- -
- Griintzig balloon catheter4F
- and superselective
streptokinase 4pOO u/min occluded vessel
12,000 u/min open vessel
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Figure 1. Scheme of treatment in the randomized
controlled trial comparing medical mechanical re-
canalization with (group II) and without (group I)
angioplasty. Cath Lab = catheterization laboratory;
i.c. = intracoronary; i.v. = intravenous; PTCA =
percutaneous trans luminal coronary angioplasty.
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therapy, the introducing sheath was sutured in place. Re-
moval of the catheter and sheath was delayed until the fol-
lowing day to minimize problems with hematoma or bleed-
ing. The patients were managed in the coronary care unit.
Serial electrocardiograms were obtained, systemic and pul-
monary artery pressures were monitored and cardiac index
was calculated.
Anticoagulation. Heparin therapy was started within 5
to 6 hours after lysis, when the initial prolongation of the
thrombin time started to decrease (25) . A full dose was
given for 3 to 4 days so that the thrombin time was prolonged
to 60 to 120 seconds. Overlapping phenprocoumon therapy
was started. Serum creatine kinase levels were determined
every 4 hours (Mercktest) or, if they were less than 200
U/liter, every 8 hours.
Cineventriculography. Before discharge, between the
third and fourth weeks after admission to the hospital, right
and left heart catheterization with coronary arteriography
was repeated. After measurement of pulmonaryartery, right
ventricular and right atrial pressures, left cineventriculog-
raphy was performed during atrial pacing at a rate corre-
sponding to that of the initial cineventriculogram during the
acute stage of infarction to exclude rate-related effects on
left ventricular function (26). In II patients in group I and
10 patients in group II left cineventriculograms in the acute
stage could not be evaluated because of ectopic beats. In
group I, a predischarge invasive study was performed in 62
(79%) of the 79 patients; 4 patients refused such study and
13 patients died. In group II, a predischarge study was
possible in 63 (76%) of the 83 patients; 10 patients refused
study and 10 patients died.
Calculation. Left ventricular volumes were determined
using a biplane disc method, as previously described (27),
with a half automatic computer system (Kontron 200,
Munchen, Germany). End-diastole was measured at the peak
of the R wave using a frame signal recorded simultaneously
with the electrocardiogram during cineventriculography at
a paper speed of 50 mm/s. End-systole was defined as the
smallest ventricular silhouette. Stroke volume and ejection
Figure 2. Analysis of regional wall motion. The end-
diastolic and end-systolic left ventricular silhouettes
arc divided into 32 segments from which regional
shortening fraction is measured (left) . On the right,
the number of pathologic segments and the sum of
the distance of the segments with a reduced wall
motion (triangles) arecompared with the normal range
(shaded area) . AW = anterior wall; PW = posterior
wall.
fraction were calculated. All volume measurements were
corrected for body surface area and expressed as indexes.
Cineventriculograms in the right anterior oblique pro-
jection were selected for regional wall motion analysis,
using a fixed system with the diastolic center of gravity as
the center point, creating 32 radii. Percent shortening of the
32 segments was calculated and normal values were estab-
lished in 30 control subjects (Fig. 2) (28). For estimation
of degree of wall motion abnormality, the number of seg-
ments with reduced shortening fraction was calculated. In
addition, the sum was obtained of the distance between the
normal range and the shortening fraction of all segments
with reduced wall motion (Fig. 2). Reperfusion of coronary
arteries was defined as total or partial opacification of the
distal part of the vessel, even with delayed washout.
In all patients in groups I and II, the stenotic vessel areas
were filmed and recorded on cinefilm in two different pro-
jections during stenosis of the right coronary artery and the
left circumflex artery and in at least three projections, in-
cluding a craniocaudal projection, in stenosis of the left
anterior descending coronary artery. From projections of
the cinefilm magnified 20 times, the degree of stenosis was
calculated using coronary catheter calibration (23).
Statistics. All results are given as mean ± SD. Student's
t test for unpaired data and the Wilcoxon test for paired data
were used, as well as the chi-square test. A probability of
less than 0.05 was regarded as signifi cant.
Results
Baseline characteristics. Analysis of the clinical data
revealed no significantdifference between group I (n = 79)
and group II (n = 83) with regard to mean age, sex, infarct
location and creatine kinase (CK) levels (Table 1). All pa-
tients developed myocardial infarction. No significant dif-
ference between groups I and II was found in relation to
time intervals between start of symptoms and treatment (Ta-
ble 2).
%
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Time From Onset of Symptoms
(min)
AMI = anterior myocardial infarction; F = female; IMI = inferior
myocardial infarction; M = male.
Table 1. Age, Sex, Infarct Location and Peak Serum Creatine
Kinase (CK) Levels for Groups I and II
Table 2. Time Intervals for Groups I and II From Onset
of Symptoms Until Admission to the Hospital and Start
of Treatment
who already had reperfusion by thrombolytic therapy, coro-
nary vessel reocclusion occurred during angioplasty.
Coronary anatomy (Fig. 3). In group I, coronary lu-
minal narrowing was 95 ± 10% before and 73 ± 19%
after recanalization (p < 0.01). Predischarge examination
revealed a coronary narrowing of 73 ± 20%. In group II,
coronary luminal narrowing measured 97 ± 7% before and
83 ± 6% after restoration of coronary blood flow (p <
0.0 I). After angioplasty, coronary stenosis was 47 ± 31%
(p < 0.0 I). Classification of the group II patients into
subgroups of those with and those without successful an-
gioplasty revealed a coronary luminal narrowing of 32 ±
18% (Fig. 3C) and 80 ± 17% (Fig. 3B), respectively.
Before discharge, coronary luminal narrowing was 29 ±
21% and 83 ± 17%, respectively. In Figures 3A and B
coronary diameter stenosis is illustrated for patients in whom
short-term as well as control studies were available.
Coronary thrombus. In 46 (28%) of the 162 patients,
a filling defect within the coronary arteries suggesting coro-
nary thrombus was found. Thrombus dissolvement during
thrombolysis was observed in 22 (48%) of the 46 patients,
whereas in 24 (52%) coronary thrombus persisted during
streptokinase infusion. Transient peripheral coronary em-
bolization was found in 5 (11%) of the 46 patients. Late
reocclusion rate was 25%, occurring in 6 of the 24 patients
with a persistent filling defect (Table 3).
Early reocclusion. In 8 (10%) of the 82 patients whose
coronary vessel was open at the time of the first coronary
angiogram, or reopened during thrombolytic therapy with-
out mechanical intervention, reocclusion occurred in the
catheterization laboratory. Mechanical recanalization, in four
patients with a G 20-30 catheter, in one patient with a 3.0
steerable balloon-tipped catheter and in three with a 3F
recanalization catheter, was successful in all eight patients.
In 10 (17%) of 60 patients reocclusion occurred after me-
chanical recanalization. The difference in comparison with
patients with reocclusion after medical reperfusion was not
significant. Mechanical reopening was possible again in all
patients, twice with a J 20-30 catheter, twice with a G 20-
30 catheter (group II) and six times with a 3F recanalization
catheter (group I).
Late reocclusion (Table 3). During the hospital stay
reocclusion, documented by a delayed CK peak despite
coronary reperfusion, a second CK peak verified by coro-
nary angiography or autopsy, occurred in 14 (20%) of the
71 patients in group I and in 10 (14%) of the 69 patients
in group II (Fig. 4). Coronary luminal narrowing in group
[ was 75 ± 17% in patients without and 87 ± 6% in patients
with reocclusion (p < 0.05). When patients in group II were
classified into those with or those without successful an-
gioplasty, reocclusion was found in 3 (7%) of 45 patients
and 7 (32%) of 22 patients, respectively; coronary luminal
narrowing was 29 ± 21 and 83 ± 17%, respectively (p <
0.001). In IS of 24 patients, reocclusion was associated
Group II
139 ± 53
30 ± 62
39 ± 23
15 ± 13
Group I
148 ± 61
20 ± 24
41 ± 18
14 ± 8
ic = intracoronary: iv = intravenous.
Until admission
Until start of iv streptokinase
Until start of ic streptokinase
Until reperfusion
Group I Group II
(n = 79) (n = 83)
Age (yr) 56.3 ± lOA 56.3 ± 10.2
>70 years I IJ79 (14%) 11/83 (13%)
Sex (M/F) 67/12 72/11
Infarct location
AMI 40 34
IMI 39 47
AMI/IMI 2
Peak CK (Ulliter) 1,183 ± 866 1,240 ± 864
Coronary recanalization. Initial coronary angiography
demonstrated an open vessel in 27 (36%) of the 79 patients
in group I (thrombolysis group) and in 21 (25%) of the 83
patients in group II (thrombolysis plus angioplasty group).
Mechanical recanalization with a 3F catheter was successful
in 30 (58%) of the 52 patients in group I and with a 4F
balloon catheter in 30 (48%) of the 62 patients in group II
with occluded coronary arteries. In 5 patients in group I and
9 patients in group II, reperfusion took place before me-
chanical recanalization could be performed, or it occurred
during superselective thrombolytic therapy in 9 patients in
group I and 12 patients in group II when mechanical re-
canalization failed. Thus, the rate of reperfusion was 90%
in group I (71 of 79 patients) and 86% in group II (71 of
83 patients). The rate of reperfusion was independent of the
obstructed coronary vessel. Time spent in the catheterization
laboratory was 72 ± 25 minutes in group I and 95 ± 33
minutes in group II (p < 0.01).
Coronary angioplasty. Immediately after the comple-
tion of streptokinase infusion, angioplasty was performed
in 69 of the 71 patients in group II who exhibited reopening
of the coronary vessel. Angioplasty was not started in two
patients because of technical problems. Angioplasty was
successful in 45 (65%) of the 69 patients and unsuccessful
in 22 (32%), with improvement of 20% of coronary luminal
narrowing considered significant. In 2 (3%) of 69 patients
Table 3. Clinical and Coronary Angiographic Data in Patients With Reocclusion in Groups I and II
CK (Ulliter)
Coronary
Coronary 2nd Peak Luminal
Luminal Coronary or Time Thrombin Stenosis
Infarct-Related Day of Narrowing Thrombus of Delayed Time ECG Before
Case Symptoms PTCA Vessel Reocclusion (%) a b 1st Peak 1st Peak (seconds) Changes Discharge Pathology
Group I
9 + RCA I 96 2,880 21h 20 + Fresh thrombus
40 + LAD 28 83 + + 1,878 1,048 16 + 100%
72 + RCA I 87 536 373 67 100% Fresh thrombus
73 + RCA 25 77 285 - 70 100%
74 LAD 13 95 661 38 - Fresh thrombus
80 LAD I 12 686 120 + 100%
85 + LAD 2 82 + + 1,275 892 21 + Fresh thrombus
86 + RCA 17 84 + + 406 1,512 18 + Fresh thrombus
104 + RCA 8 80 + 1,346 457 25 + - Fresh thrombus
109 RCA 5 90 + + 825 - 100%
133 LCx 26 50 864 - 17 100%
142 + LAD 2 90 834 846 17
144 + RCA 5 90 1,554 275 23
152 + LAD 20 1,052 146 120 100%
Group II Successful PTCA
II + + RCA I 62 853 507 120 + 100%
95 + + LAD 14 20 401 + 100%
103 + + LAD 3 33 1,570 170 54 + 100%
Unsuccessful PTCA
10 + RCA I 83 + + 890 984 120 + 100%
39 + RCA I 97 1,620 36h 47 100%
49 + LAD I 76 525 21h 37 + 100%
76 + RCA 84 + + 1,105 30h 72 100%
97 + RCA I 85 951 20h 120 100%
106 + + RCA 27 85 + 4,250 224 - + 100%
161 + + RCA 8 90 726 306 120 100%
a and b = first and last. respectively, coronary angiography in the acute study; CK = creatine kinase; ECG = electrocardiogram; h hours; LAD = left anterior
descending coronary artery; LCx = left circumflex coronary artery; PTCA = percutaneous transluminal coronary angioplasty: RCA = right coronary artery.
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with new symptoms and a second or delayed CK peak and
electrocardiographic changes. In the first coronary angio-
gram, a coronary thrombus, producing a filling defect distal
to the coronary stenosis despite an open vessel, was found
in 9 (37%) of the 24 patients demonstrating reocclusion. In
59% of the patients reocclusion occurred during the first 5
days.
Left ventricular function. Comparison of left ventric-
ular volumes and ejection fraction is demonstrated in Table
4. Both treatment groups demonstrated no significant change
in left ventricular ejection fraction. In the acute stage of
infarction, end-diastolic and end-systolic volumes were not
significantly higher in group II than in group I. No difference
was observed before hospital discharge. Classification of
group II into patients with and those without successful
angioplasty revealed no significant change in ejection frac-
tion. Early and predischarge ejection fraction was 56 ± II
and 56 ± 13%, respectively, in the first subgroup and 58
± 14 and 54 ± 17%, respectively, in the second subgroup.
Significant increases in end-diastolic and end-systolic
volumes were observed in group I patients, and in end-
systolic volume in group II patients. In patients with inferior
myocardial infarction, no significant difference was found
between groups I and II.
Regional wall motion. The changes in the number of
pathologic segments and the sum of the distance between
the normal range and the shortening of each segment are
given in Table 5. A significant improvement in regional
wall motion was found in group II patients with anterior
myocardial infarction but not in group I patients (Fig. 5).
In group I patients with inferior myocardial infarction, only
a reduction of the shortening fraction of the segments of the
contralateral wall was observed during the hospital stay
(Fig. 6).
Hospital mortality. During the hospital stay II (14%)
of the 79 patients in group I and 6 (7%) of the 83 patients
in group II died of cardiac causes. In addition, in group II
three cases of adult respiratory distress syndrome and one
case of cerebral bleeding were observed. In group I, one
patient died from pneumonia and one had cerebral bleeding.
In group I, one ventricular septal defect and one free wall
rupture and in group II one free wall rupture were observed.
The latter patient was operated on immediately but died
later of septic shock (Table 6).
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Figure 3. Coronaryluminalnarrowing. A, Group I (streptokinase
plus mechanical revascularization) before and after thrombolysis
therapy in the acute stage as well as in the predischarge study,
including patients with control coronary angiography before dis-
charge. 8 and C, Group II (streptokinase plus angioplasty) before
and after thrombolysis therapy combined with successful (8) and
unsuccessful (C) angioplasty. Mean values ± SD.
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Discussion
Rapid restoration of coronary blood flow as soon as pos-
sible seems to be the aim of therapy in acute myocardial
infarction. Thrombolysis can be achieved by intravenous
and intracoronary administration of streptokinase and uro-
kinase, as well as tissue type plasminogen activator (1-17 ,29).
Previous studies demonstrated that mechanical recanaliza-
tion also can be performed by recanalization or angioplasty
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Figure 4. Follow-up results of patients in group
I (A) and group II (B) during the hospital stay.
PTCA = percutaneous transluminal coronary
angioplasty.
catheters in both acute (20,21,30) and chronic (31) myo-
cardial infarction, Even mainstem occlusions could be re-
canalized (32). By combining thrombolytic therapy with the
mechanical approach, the rate of recanalization could be
increased up to 88% (20) using 3F recanalization or 4F
angioplasty catheter without coronary perforation; this was
observed in previous studies (33) in 4% using guide wires,
Combined thrombolytic therapy and angioplasty.
Combined intravenous and intracoronary thrombolytic ther-
apy with streptokinase was performed to increase the rate
of open vessels seen in the first coronary angiogram. Our
results are confirmed by other investigators (18,19) who
reported high rates of open coronary vessels after intrave-
nous application of streptokinase before beginning intra-
coronary streptokinase infusion. In studies with intracoro-
nary thrombolytic therapy, a mean value of only 19% of
initially open coronary vessels was reported (10,12).
In our study recanalization with 3F and 4F balloon-tipped
catheters was achieved within 15 minutes. This is shorter
than the time reported for intracoronary thrombolytic ther-
apy alone, which has ranged from 23 ± 15 minutes (9) to
36 ± 8 minutes (33).
Table 4. End-Diastolic and End-Systolic Volume Indexes, Stroke Volume Index and Ejection Fraction in Groups I and II After
Medical Mechanical Recanalization and Before Discharge
EOVI (rnl/rrr') ESVI (rnl/rrr') SVI (ml/m") EF(%)
No. a b a b a b a b
Group I (n = 51) 85 96* 37 46* 48 51 57 55
X ±SO 18 31 10 26 14 13 9 13
Anterior MI (n = 27) 83 97* 39 49 44 48 53 52
X ±SO 18 39 11 33 13 15 9 14
Inferior MI (n = 24) 87 94 34 41* 53 53 61 59
X ±SO 19 19 9 16 13 9 8 11
Group II (n = 53) 91 99 40 46* 52 52 57 55
X ±SO 22 26 15 21 16 16 12 14
Anterior MI (n = 20) 91 102 44 47 47 55 52 55
X ±SO 18 23 16 24 12 18 12 17
Inferior MI (n = 33) 91 97 37 46* 55 51 60 54
X ±SO 24 27 14 20 17 14 II 12
The mean values (X)and standard deviation (SO) are indicated; Wilcoxon test for statistical analysis, * p < 0.05. a = acute study; b = predischarge
study; EOVI = end-diastolic volume index; EF = ejection fraction; ESVI = end-systolic volume index; MI = myocardial infarction; SVI = stroke
volume index.
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Table S. Regional Wall Motion Analysis in Groups I and II Group IIWI
Anterior wall infarction 12.4 12.9 13.2 9.4
X ±SD 3.6 7.3 9 .6 5. 1
Inferior wall infarction 9.2 8.5 10 .6 10 .9
X ±SD 4.2 9 .3 8.5 5. 1
Group I
a b
No. of pathologic segments
Group II
a b
SF
%
50
Ot-- - - - - - - - - - - - - - - - - -
Sum of pathologic segments (0/0 )
Anterior wall infarction
X ± SD
Inferior wall infarction
X ± SD
14.77
3.95
11.04
5.9 8
11.61*
5.38
11.28
6.56
12.41
4.44
12.5
6.02
9.67*
6.1 3
12.82
5.70
50 100
PW
150 200
Apex
_acute
• •.• control
250 300deg,..
AW
*p < 0 .0 I, Wilcoxon test for statistical analysis. The number of patho-
logic segments and sum of the distance of the fractional shortening of the
different segments with a normal range are shown (see Fig . 2).
Figure S. Regional wall motion of patients with anterior wall
infarction (AWl) in group I (A) and group II (B), with shortening
fraction (SF) of 32 radii (mean values and SO) in the acute and
predischarge coronary angiograms. Normal range is illustrated as
a shaded area. Triangles indicate p < 0.05. AW = anterior wall:
PW = posterior wall.
Group II
IWI
SF
%
50
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Figure 6. Regional wall motion of patients with inferior myo-
cardial infarction (lWI) in group I (A) and group II (B), with
shortening fraction (SF) of 32 radii (indicated with mean values
and standard deviation) in the acute and predischarge coronary
angiogram. Normal range is illustrated as a shaded area . Abbre-
viations as in Figure 5.
More than half of all occluded vess els could be me-
chanic ally recanalized by angioplas ty. Onl y in a few cases
50 100 150 200 250 300deg,.. d id the mechanical approach fail. By combining thrornbo-PW Apex AW
lytic and mechanical recanal izat ion , the reperfusion rate
reached 90%. By con ventional thrombolytic therapy, the
Group II reperfusion rate has ranged from 60% (8) to 86% (29) , with
AWl a mean of about 70% (9, 12,13,2 1.34-36). Even combi-
SF
llU
nation with nitroglycerin produced a reperfusion rate of only
% 77% (37).50 J1Ul1lL~ Coronary thrombus. According to other investigators\\111. (8,38 ,39), coronary thrombus was found after restorat ionof coronary blood flow, cle arl y supporting the concept of
co mbining mechanical recanal izat ion with thrombolytic
therapy to dissolve co ronary thrombus . Coronary embo li-
0
zation was ob served by Terrosu et al. (38) in 9% of cases
with co nsecutive lysi s of the embolis m . Dissolution during
50 100 150 200 250 300 degree
intr acoronary administration of streptokinase of the coronary
PW Apex AW thrombus was found in 43%.
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Table 6. Hospital Mortality in Groups I and II With Indication of Cause of Death and the Day
of Death After Myocardial Infarction
Group I (n = 79) Group II (n = 83)
Cause of Death Day Cause of Death Day
Patients with cardiac cause of death*
6 Reinfarctions 2, 3, 4, 7, 8, 17 2 Reinfarctions 2, 2
2 Cardiac ruptures 2, 2 I Cardiac rupture 14
I Asystole I
I Sudden death 13
I Cardiogenic shock I 3 Cardiogenic shock I, I, I
Patients with noncardiac cause of deatht
I Pneumonia 22 3 Shock lung 7,9, 13
I Cerebral bleeding 7 I Cerebral bleeding I
*Eleven (14%) of 79 patients in Group I and 6 (77%) of 83 patients in Group II; t2 (3%) of 79 patients
in Group I and 4 (5%) of 83 patients in Group II.
Reocclusion. In patients with mechanical recanalization
by angioplasty, the reocelusion rate in the catheterization
laboratory was higher than in patients with an open coronary
vessel or in those with reperfusion during thrombolytic ther-
apy (10 and 17%, respectively). This is perhaps related to
the fact that after angioplasty a lot of thrombotic material
is left on the coronary artery wall. Reperfusion during
thrombolysis seems to eliminate more thrombotic material,
explaining the reduction of the reocelusion rate in this group.
On the other hand, mechanical recanalization is faster than
thrombolysis. In all cases of reocelusion, recanalization could
be performed again mechanically giving permanent per-
fusion.
Reocclusion during the hospital stay occurred in 20% of
patients with successful reperfusion in group I and in 14%
in group II. Other investigators similarly described a reoc-
elusion rate of 17% (39) and 18% (29). According to other
reports (40-43), reocelusion was dependent on the degree
of luminal narrowing after reperfusion. Coronary stenoses
were significantly higher in our patients in group I with
reocclusion compared with those without reocclusion. These
results are in accordance with the work of Schwarz and
Kubler (42), who reported a reocelusion rate of 8% in pa-
tients with less than 70% coronary luminal narrowing and
of 26% in those with greater than 70% narrowing. Serruys
et al. (41) recorded a reocelusion rate of 17% in 42 patients
after attempted thrombolysis and of 5.5% in 18 patients
after additional angioplasty using anticoagulant therapy dur-
ing the hospital stay; others, using antiplatelet agents or low
dose heparin therapy, reported reocelusion rates of 35% (44)
and 33% (45). Angioplasty reduced coronary luminal nar-
rowing in our patients significantly. The rate of reocelusion
was found to be only 7% in patients with successful angio-
plasty, but 32% in those with unsuccessful angioplasty caused
by high grade residual stenosis.
Thus, immediate elimination of the underlying stenosis
either by subsequent angioplasty (23,41) or by early bypass
surgery (46,47) seems to be a reasonable procedure. If,
however, treatment of the stenosis is necessary, it should
not be postponed, because perfusion would be reduced dur-
ing a waiting period and our results indicate that the rate of
reocelusion is highest during the first 5 days after throm-
bolytic treatment.
Reocclusion during the hospital stay may also be depen-
dent on continuous full heparinization (10). In two of three
cases of successful angioplasty and reocelusion, an inter-
mittent normalization of thrombin time was observed. One
other factor is the persistence of coronary thrombus, because
in these cases the rate of rethrombosis is high, reaching 30%
in our study. Prolonged streptokinase infusion should be
considered in cases of persistent thrombus.
Does reocclusion mean reinfarction? To evaluate this
problem, clinical and electrographic data were reevaluated.
A second CK peak was observed in 13 of 24 patients and
a delayed CK peak in 5 of 24 patients with reocelusion.
Not all patients were symptomatic (63%); not all had new
electrocardiographic changes. This means that reocelusion
seems to be combined with reinfarction but is asymptomatic
in some patients. The degree of the new CK elevation and
the additional electrocardiographic changes may allow es-
timation of the effect of reperfusion on infarct size and
salvaged myocardium.
Ventricular function. The first cineventriculogram was
performed after restoration of coronary blood flow. There-
fore, any possible changes in left ventricular function before
and after recanalization would not have been detected. How-
ever, such changes appear to be slight (48). To rule out
heart rate-related changes in left ventricular function, all
patients underwent cardiac pacing at heart rates correspond-
ing to those on the control cineventriculogram before dis-
charge (26).
The mean ejection fraction was found to be higher in
inferior than in anterior myocardial infarction (49). Also,
previous reports (8,20,50) described only minor changes in
ejection fraction after thrombolytic therapy. A significant
increase in left ventricular ejection fraction was reported
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only in subgroups, such as those where the coronary vessel
was already open at the time of the first coronary angiogram
(9,34,47).
Regional wall motion. Regional wall motion improved
significantly in our patients with anterior myocardial in-
farction treated with angioplasty, whereas in the group with-
out angioplasty regional wall motion was almost unchanged.
Increased wall motion of the contralateral wall decreased
during the hospital stay. These results are in accordance
with those of Sheehan et al. (47), who noted a significant
improvement only in patients with thrombolytic therapy and
subsequent aortocoronary bypass surgery.
For patients with inferior myocardial infarction, the ob-
served changes were only slight. In most patients a decrease
in motion of the contralateral wall was observed combined
with a slight decrease in global left ventricular ejection
fraction, which remained, however, in the lower normal
range.
Hospital mortality. This was found to be 22% in pa-
tients admitted to hospital within 4 hours after the onset of
symptoms (51). In a conventionally treated group (36) a
mortality rate of 19% was found for patients with anterior
and 4.8% for patients with inferior myocardial infarction.
High mortality rates were reported particularly in patients
without reperfusion (9,19). Previous uncontrolled studies
(9,10,19,29) reported mortality rates of between 7 and 10%.
Rentrop et al. (37) reported a mortality rate of 13% in
patients treated with nitroglycerin, 20% in those treated with
streptokinase and 22% in those treated with streptokinase
and nitroglycerin. In our study mortality was 14% in group
I (thrombolysis group), whereas it was 8% in group II
(thrombolysis plus angioplasty). In three additional patients
in group II, adult respiratory distress syndrome developed.
One patient from this group developed cerebral bleeding,
as previously reported by others (17,45).
Clinical implications. This randomized study demon-
strates that by combined thrombolytic-mechanical recanal-
ization with either a 3F recanalization or 4F balloon-tipped
catheter a rate of reperfusion of 90% can be reached in
patients with acute myocardial infarction. Immediate elim-
ination of underlying flow-limiting coronary stenosis by an-
gioplasty improves regional wall motion in anterior myo-
cardial infarction and reduces the reocclusion and reinfarction
rate from 20 to 7%. By a combination of thrombolytic
therapy and immediate elimination of the underlying flow-
limiting coronary stenosis by angioplasty, regional left ven-
tricular function improves in patients with anterior myo-
cardial infarction. Successful angioplasty, not the intention
to perform angioplasty, reduces reocclusion rates. Assign-
ment to angioplasty does not change reocclusion rates.
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